Epigenetic regulation of breast cancer metastasis

被引:12
作者
Thakur, Chitra [1 ]
Qiu, Yiran [1 ]
Pawar, Aashna [1 ]
Chen, Fei [1 ]
机构
[1] SUNY Stony Brook, Stony Brook Canc Ctr, Renaissance Sch Med, Lauterbur Dr, Stony Brook, NY 11794 USA
基金
美国国家卫生研究院;
关键词
Breast cancer; Metastasis; Epigenetic regulation; EPITHELIAL-MESENCHYMAL TRANSITION; DISSEMINATED TUMOR-CELLS; SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE INHIBITORS; HYPOXIA-INDUCIBLE FACTOR-1; INDUCED LYSYL OXIDASE; DNA METHYLATION; STEM-CELLS; BONE-MARROW; ABERRANT EXPRESSION;
D O I
10.1007/s10555-023-10146-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is the most frequently diagnosed malignancy and the second leading cause of cancer-related mortality among women worldwide. Recurrent metastasis is associated with poor patient outcomes and poses a significant challenge in breast cancer therapies. Cancer cells adapting to a new tissue microenvironment is the key event in distant metastasis development, where the disseminating tumor cells are likely to acquire genetic and epigenetic alterations during the process of metastatic colonization. Despite several decades of research in this field, the exact mechanisms governing metastasis are not fully understood. However, emerging body of evidence indicates that in addition to genetic changes, epigenetic reprogramming of cancer cells and the metastatic niche are paramount toward successful metastasis. Here, we review and discuss the latest knowledge about the salient attributes of metastasis and epigenetic regulation in breast cancer and crucial research domains that need further investigation.
引用
收藏
页码:597 / 619
页数:23
相关论文
共 353 条
[1]   Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease [J].
Acloque, Herve ;
Adams, Meghan S. ;
Fishwick, Katherine ;
Bronner-Fraser, Marianne ;
Angela Nieto, M. .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (06) :1438-1449
[2]   Epigenetic Therapeutics: A New Weapon in the War Against Cancer [J].
Ahuja, Nita ;
Sharma, Anup R. ;
Baylin, Stephen B. .
ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 :73-89
[3]   Paget's "Seed and Soil" Theory of Cancer Metastasis: An Idea Whose Time has Come [J].
Akhtar, Mohammed ;
Haider, Abdulrazzaq ;
Rashid, Sameera ;
Al-Nabet, Ajayeb Dakhilalla M. H. .
ADVANCES IN ANATOMIC PATHOLOGY, 2019, 26 (01) :69-74
[4]   Autophagy and Cancer Dormancy [J].
Akkoc, Yunus ;
Peker, Nesibe ;
Akcay, Arzu ;
Gozuacik, Devrim .
FRONTIERS IN ONCOLOGY, 2021, 11
[5]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[6]   Self-renewal and solid tumor stem cells [J].
Al-Hajj, M ;
Clarke, MF .
ONCOGENE, 2004, 23 (43) :7274-7282
[7]   Histone deacetylase inhibitor trichostatin a represses estrogen receptor α-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines [J].
Alao, JP ;
Lam, EWF ;
Ali, S ;
Buluwela, L ;
Bordogna, W ;
Lockey, P ;
Varshochi, R ;
Stavropoulou, AV ;
Coombes, RC ;
Vigushin, DM .
CLINICAL CANCER RESEARCH, 2004, 10 (23) :8094-8104
[8]   Expression of metastasis-associated genes h-mtsl (S100A4) and nm23 in carcinoma of breast is related to disease progression [J].
Albertazzi, E ;
Cajone, F ;
Leone, BE ;
Naguib, RNG ;
Lakshmi, MS ;
Sherbet, GV .
DNA AND CELL BIOLOGY, 1998, 17 (04) :335-342
[9]   Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents [J].
Andre, F. ;
Zielinski, C. C. .
ANNALS OF ONCOLOGY, 2012, 23 :46-51
[10]   PGC-1α Promotes Breast Cancer Metastasis and Confers Bioenergetic Flexibility against Metabolic Drugs [J].
Andrzejewski, Sylvia ;
Klimcakova, Eva ;
Johnson, Radia M. ;
Tabaries, Sebastien ;
Annis, Matthew G. ;
McGuirk, Shawn ;
Northey, Jason J. ;
Chenard, Valerie ;
Sriram, Urshila ;
Papadopoli, David J. ;
Siegel, Peter M. ;
St-Pierre, Julie .
CELL METABOLISM, 2017, 26 (05) :778-+